Benign prostatic hyperplasia Posts on Medivizor
Navigation Menu

Benign prostatic hyperplasia Posts on Medivizor

Metabolic syndrome and smoking are associated with nocturia after transurethral resection of the prostate

Posted by on Jul 8, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study aimed to evaluate the link between smoking, metabolic syndrome (MetS) and side-effects after prostate surgery. This study found smoking and MetS led to a higher risk of nocturia (waking at night to urinate). Some background Transurethral resection of the prostate (TURP) is a surgery used to treat urinary problems due...

Read More

Can vitamin D3 supplementation protect against recurrent urinary infections among patients with benign prostatic hyperplasia?

Posted by on Jun 30, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study aimed to investigate the use of cholecalciferol (vitamin D3) for the prevention of recurrent urinary tract infections (UTIs) for men with benign prostate hyperplasia (BPH). This study found that vitamin D3 supplementation may be protective against recurrent UTIs among patients with BPH. Some background People diagnosed with...

Read More

Evaluating outcomes of prostate botulinum toxin-A injections for benign prostatic hyperplasia

Posted by on Jun 30, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This article investigated the safety and effectiveness of botulinum toxin-A (BTX-A) injections for the treatment of the lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). The authors concluded that BTX-A injections are a safe and effective treatment option for these patients.   Some background Lower...

Read More

Laser vaporesection vs plasmakinetic resection for the treatment of benign prostate obstruction

Posted by on May 31, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This article investigated the safety and effectiveness of multipulse laser vaporesection of the prostate (MPVP) vs plasmakinetic resection of the prostate (PKRP) for patients with benign prostate obstruction (BPO).  The authors concluded that MPVP might be a better treatment option for patients with BPO.  Some background...

Read More

Evaluating long-term effects of Aquablation vs TURP for benign prostatic hyperplasia

Posted by on May 30, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This article investigated the long-term safety and effectiveness of Aquablation vs transurethral resection of the prostate (TURP) for the treatment of urinary symptoms related to benign prostate hyperplasia (BPH; an enlarged prostate). The authors concluded that the two procedures had similar safety and effectiveness after 2 years. Some...

Read More

Is Aquablation an effective treatment for urinary symptoms caused by an enlarged prostate?

Posted by on May 20, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell The authors analyzed the effectiveness of Aquablation compared to other treatments for patients with urinary symptoms caused by an enlarged prostate. The authors concluded that Aquablation is probably as effective as transurethral resection of the prostate (TURP) in these patients. Some background An enlarged prostate may cause...

Read More

Are men taking 5α-reductase inhibitors for an enlarged prostate more likely to develop type 2 diabetes?

Posted by on Apr 30, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study examined if men taking 5α-reductase inhibitors (5ARIs) for benign prostatic hyperplasia (BPH) are more likely to develop type 2 diabetes (T2D). This study concluded the risk of developing T2D is higher in patients taking 5ARIs for BPH, compared to alpha blockers.  Some background Benign Prostatic Hyperplasia...

Read More

Effective drug combinations for the treatment of overactive bladder in patients with benign prostatic hyperplasia

Posted by on Apr 21, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study investigated drug combinations with silodosin (Rapaflo) to treat overactive bladder (OAB) in men with benign prostatic hyperplasia (BPH).  They found that fesoterodine (Toviaz) was more effective than mirabegron (Mirbetriq) as add-ons to silodosin in these patients. Some background Benign...

Read More

Is Serenoa repens (saw palmetto) a safe and effective treatment for benign prostatic hyperplasia?


Posted by on Apr 12, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study examined if Serenoa repens (commonly known as saw palmetto) is a safe and effective treatment for benign prostatic hyperplasia (BPH). This study concluded that Serenoa repens is a safe and effective treatment for BPH. Some background BPH is a non-cancerous overgrowth of the prostate. These patients are commonly bothered by...

Read More

Can the ACTIONS health measurement scale be used to predict the outcomes after prostate surgery?

Posted by on Mar 31, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study examined if the ACTIONS (Anxiety, Cardiovascular, Testosterone, Insulin/diabetes, Obesity, Neurologic, Sleep apnea) health measurement scale be used to predict the outcomes after prostate surgery for benign prostatic hyperplasia (BPH). This study concluded the ACTIONS score could be used to help counseling men considering...

Read More

Does diet impact BPH, LUTS and ED?

Posted by on Mar 16, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This review aimed to investigate a link between diet and benign prostatic hyperplasia (BPH). Some background People diagnosed with benign prostatic hyperplasia (non-cancerous overgrowth of the prostate; BPH) can experience erectile dysfunction (ED). This is the inability to get or keep an erection firm enough to have sexual...

Read More